Quantum-Si Past Earnings Performance
Past criteria checks 0/6
Quantum-Si's earnings have been declining at an average annual rate of -26.7%, while the Life Sciences industry saw earnings growing at 16.4% annually. Revenues have been growing at an average rate of 144.3% per year.
Key information
-26.7%
Earnings growth rate
75.2%
EPS growth rate
| Life Sciences Industry Growth | 21.5% |
| Revenue growth rate | 144.3% |
| Return on equity | -35.3% |
| Net Margin | -8,868.8% |
| Next Earnings Update | 09 May 2024 |
Recent past performance updates
Recent updates
Quantum-Si (NASDAQ:QSI) Is In A Good Position To Deliver On Growth Plans
Apr 19
Quantum-Si: Commercial Lift Imminent
Feb 05Companies Like Quantum-Si (NASDAQ:QSI) Are In A Position To Invest In Growth
Dec 04We Think Quantum-Si (NASDAQ:QSI) Can Afford To Drive Business Growth
Jun 28Jeff Hawkins is the new CEO of Quantum-Si
Oct 04Quantum-Si: Semiconductor-Based Next Generation Protein Sequencing Platform
Sep 24Quantum-Si: Merging Semiconductors With Biology Will Scale Things Fast
Jul 30Proteomics May Be The Future Of Biotech, Quantum-Si Is A Potential Leader
Jul 11Revenue & Expenses BreakdownBeta
How Quantum-Si makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1 | -96 | 43 | 64 |
| 30 Sep 23 | 1 | -107 | 43 | 66 |
| 30 Jun 23 | 0 | -114 | 44 | 68 |
| 31 Mar 23 | 0 | -121 | 45 | 71 |
| 31 Dec 22 | 0 | -132 | 42 | 72 |
| 30 Sep 22 | 0 | -129 | 40 | 66 |
| 30 Jun 22 | 0 | -115 | 48 | 63 |
| 31 Mar 22 | 0 | -118 | 50 | 55 |
| 31 Dec 21 | 0 | -95 | 50 | 47 |
| 30 Sep 21 | 0 | -75 | 40 | 39 |
| 30 Jun 21 | 0 | -66 | 23 | 32 |
| 31 Mar 21 | 0 | -38 | 10 | 28 |
| 31 Dec 20 | 0 | -37 | 9 | 28 |
Quality Earnings: QSI is currently unprofitable.
Growing Profit Margin: QSI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: QSI is unprofitable, and losses have increased over the past 5 years at a rate of 26.7% per year.
Accelerating Growth: Unable to compare QSI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: QSI is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-9.3%).
Return on Equity
High ROE: QSI has a negative Return on Equity (-35.33%), as it is currently unprofitable.